Sustained Therapeutics
Vancouver · Founded 2020
About Sustained Therapeutics
Sustained Therapeutics is a platform that allows the production of sustained-release formulations of generic drugs. Preliminary data from the lead candidate (ST-01) from a completed Phase I clinical trials for the treatment of chronic scrotal pain demonstrated sustained pain relief over a period of up to four weeks with a single injection. Sustained Therapeutics is backed by Creative Destruction Labs.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Seed (Aug 2022)
- Website: https://sustainedtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sustained-therapeutics-118746 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.